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background
 
Recent studies have demonstrated that exercise capacity is an independent predictor of
mortality in women. Normative values of exercise capacity for age in women have not
been well established. Our objectives were to construct a nomogram to permit deter-
mination of predicted exercise capacity for age in women and to assess the predictive
value of the nomogram with respect to survival.
 
methods
 
A total of 5721 asymptomatic women underwent a symptom-limited, maximal stress
test. Exercise capacity was measured in metabolic equivalents (MET). Linear regres-
sion was used to estimate the mean MET achieved for age. A nomogram was estab-
lished to allow the percentage of predicted exercise capacity to be estimated on the basis
of age and the exercise capacity achieved. The nomogram was then used to determine
the percentage of predicted exercise capacity for both the original cohort and a referral
population of 4471 women with cardiovascular symptoms who underwent a symp-
tom-limited stress test. Survival data were obtained for both cohorts, and Cox survival
analysis was used to estimate the rates of death from any cause and from cardiac causes
in each group.
 
results
 
The linear regression equation for predicted exercise capacity (in MET) on the basis of
age in the cohort of asymptomatic women was as follows: predicted MET=14.7¡
(0.13¬age). The risk of death among asymptomatic women whose exercise capacity
was less than 85 percent of the predicted value for age was twice that among women
whose exercise capacity was at least 85 percent of the age-predicted value (P<0.001).
Results were similar in the cohort of symptomatic women.
 
conclusions
 
We have established a nomogram for predicted exercise capacity on the basis of age
that is predictive of survival among both asymptomatic and symptomatic women.
These findings could be incorporated into the interpretation of exercise stress tests,
providing additional prognostic information for risk stratification.
abstract
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xercise capacity is an independent
 
predictor of the risk of death and cardiac
events among asymptomatic women and
men.
 
1-5
 
 Exercise capacity may be defined as the
maximal oxygen uptake for a given workload
 
6,7
 
 and
can be expressed in metabolic equivalents (MET),
or multiples of the basal rate of oxygen consump-
tion when a person is at rest (3.5 ml per kilogram
of body weight per minute for an average adult).
 
8
 
Exercise capacity can be estimated by performing a
symptom-limited stress test.
Exercise capacity varies with age, sex, and health.
A number of studies have established that there is
a negative linear relationship between exercise ca-
pacity and age in men, and a nomogram has been
developed for men that estimates the percentage of
predicted exercise capacity for a given age.
 
6,7,9-11
 
Few studies have evaluated exercise capacity in
women, and to date, no standard for age-related
declines in physical fitness has been established
for women.
We had two goals in conducting this study. The
first was to create a simple nomogram for women
to allow the conversion of the MET value achieved
on a stress test into a percentage of the predicted
exercise capacity for any age, on the basis of findings
in a population of asymptomatic women. The sec-
ond goal was to assess the usefulness of the nomo-
gram in predicting survival among both asymptom-
atic women and a referral population of women
with cardiovascular symptoms in order to deter-
mine its usefulness in clinical practice.
 
asymptomatic population
 
The asymptomatic population came from the St.
James Women Take Heart Project. This cohort has
previously been described.
 
1
 
 Briefly, in 1992 volun-
teers were solicited from the Chicago metropoli-
tan area to participate in a study of heart disease
in women. The project was approved by the insti-
tutional review board of St. James Hospital and
Rush–Presbyterian–St. Luke’s Medical Center, with
written informed consent obtained from all study
participants.
Inclusion criteria for the study cohort were an
age of at least 35 years and the ability to walk on a
treadmill at a moderate pace. Women were exclud-
ed if they were pregnant, had typical anginal symp-
toms or any history of cardiac disease (including
previous myocardial infarction, documented coro-
nary artery disease, heart failure, or valvular heart
disease), weighed more than 148 kg (325 lb), had a
baseline blood pressure of 170/110 mm Hg or high-
er, or had incomplete data concerning cardiac risk
factors. Members of the cohort were classified as
sedentary or active on the basis of their response to
one question: Do you have a regular (exercise) train-
ing program?
 
referral population
 
The referral population came from the Economics
of Noninvasive Diagnosis Study, which has been de-
scribed previously.
 
12,13
 
 Briefly, this cohort was
composed of consecutive women from six medical
centers who were referred between 1990 and 1995
for a symptom-limited exercise stress test with the
use of the Bruce protocol
 
14
 
 for the evaluation of
suspected coronary disease. Women were excluded
if they had recently been hospitalized for unstable
angina, myocardial infarction, or coronary revascu-
larization. The study was approved by the institu-
tional review board at each of the six participating
centers. For all but one site, written informed con-
sent for follow-up was obtained at the time of the
initial procedure. For the remaining site, the re-
quirement for informed consent was waived by the
institutional review board because the data were
from a previously approved database.
 
exercise treadmill testing
 
All participants underwent a symptom-limited
treadmill test according to the Bruce protocol.
 
14
 
The test was discontinued in the event of limiting
symptoms (angina, dyspnea, or fatigue), abnormal-
ities of rhythm or blood pressure, or marked and
progressive ST-segment deviation. Target heart
rates were not used as a predetermined end point.
In the asymptomatic group, some participants
underwent stress testing according to a modified
Bruce protocol. These women were excluded from
the analysis, because submaximal exercise testing
does not accurately reflect physical fitness in the
way that maximal exercise testing does.
 
exercise capacity
 
The estimated exercise capacity was measured in
MET
 
6,7
 
 as defined above. The estimate was based
on the speed and grade of the treadmill.
 
15
 
follow-up data
 
The number of deaths from any cause in the asymp-
tomatic cohort was determined by searching the
e
methods
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National Death Index to identify deaths and causes
of death from the time of the baseline evaluation in
1992 through the end of 2000. Follow-up informa-
tion was obtained on the referral (symptomatic)
population through 2000 during a clinic visit or
telephone interview. Deaths were identified and the
cause of death was classified after a review of death
certificates by an independent reviewer who was
unaware of the women’s clinical history and stress-
testing data.
 
statistical analysis
 
The MET achieved was determined from the final
speed and grade of the treadmill, as defined for the
Bruce protocol.
 
15
 
 Using the asymptomatic popula-
tion, we calculated the linear regression of exercise
capacity (in MET) on age; no evidence of nonlin-
earity was found. The calculated value from the re-
gression equation for age was defined as 100 per-
cent of the age-predicted exercise capacity.
For each participant in both groups, the per-
centage of the predicted exercise capacity achieved
for age was then calculated with the use of the fol-
lowing equation: percentage of predicted exercise
capacity achieved for age=(observed MET÷ age-
predicted MET)¬100. A nomogram to determine
the percentage of predicted exercise capacity for
age was constructed with the use of the linear re-
gression equation for the asymptomatic cohort.
Similarly, separate nomograms were also created
for both the active and sedentary groups.
The correlation of the percentage of predicted
exercise capacity for any given age with subsequent
survival was calculated in both groups. The rates
of death from any cause and from cardiac causes
were analyzed for both populations with the use of
univariate Cox proportional-hazards models, on
the basis of the deviation from the predicted nor-
mal value of exercise capacity for age. From the Cox
models, the predicted rates of death from cardiac
causes were plotted against the ratio of observed
exercise capacity to expected exercise capacity, and
an r
 
2
 
 statistic was calculated. Annualized death
rates and rates of death from cardiac causes were
calculated by dividing the predicted death rates
from the Cox model by the length of follow-up. All
analyses were performed with the use of STATA
software (version 8.0) or SPSS software (version
12.0). A two-sided P value of less than 0.05 was
considered to indicate statistical significance.
A total of 5721 asymptomatic women and 4471
symptomatic women met the study-specific in-
clusion criteria.
 
1,12,13,16
 
 The characteristics of the
two cohorts are shown in Table 1. The asymptom-
atic cohort was younger than the symptomatic co-
hort and was predominantly white (85 percent).
Although the majority of the symptomatic women
were white, almost a third were black. Fewer asymp-
tomatic women had a history of hypertension or
diabetes. Atypical symptoms accounted for only a
quarter of the symptoms in the symptomatic co-
hort. The asymptomatic women had a higher mean
exercise capacity and a lower overall mortality rate
during the follow-up period than did the symptom-
atic women.
results
 
* Plus–minus values are means ±SD. CAD denotes coronary artery disease, 
CP chest pain, and CHF congestive heart failure.
 
† Race and risk factors were self-reported.
 
Table 1. Characteristics of the Study Cohorts.*
Characteristic
Asymptomatic 
Women 
(N=5721)
Symptomatic 
Women 
(N=4471)
 
Age — yr
Mean 52±11 61±12
Range 35–86 34–93
Race — %†
White 85 62
Black 9 28
Other 6 10
Risk factors — %†
Hypertension 17 49
Diabetes 5 22
Current or former smoker 21 25
Family history of CAD 44 35
Hypercholesterolemia 17 12
Typical angina — % — 58
Atypical or nonanginal CP — % — 25
Dyspnea or symptoms of CHF — % — 17
Exercise capacity — MET
Peak 8.0±2.7 6.9±3.4
Range 1.4–20.0 1.2–17.4
Death — no. (%)
Any cause 180 (3) 537 (12)
Cardiac causes 58 (1) 45 (1)
Duration of follow-up — yr 8.4±0.7 5.3±2.1
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predicted exercise capacity
 
The relationship between exercise capacity and age
in the cohort of 5721 asymptomatic women was
linear. Regression analysis of exercise capacity for
age yielded the following equation: predicted
MET=14.7¡(0.13¬age), with an age-adjusted SD
of 2.3 (r= ¡0.51, P<0.001).
The same regression analysis was stratified ac-
cording to the level of reported activity. A total of
212 women did not respond to the exercise ques-
tion and were excluded from this analysis. For the
active subgroup of 866 women, the regression
equation was as follows: predicted MET=17.9¡
(0.16¬age), with an age-adjusted SD of 2.4 (r=
¡0.59, P<0.001). For the sedentary subgroup of
4643 women, the regression equation was as fol-
lows: predicted MET=14.0¡(0.12¬age), with an
age-adjusted SD of 2.2 (r= ¡0.49, P<0.001).
The nomogram for the entire asymptomatic
population (the first equation) is shown in Figure 1,
with the previously reported nomogram for asymp-
tomatic men provided for comparison.
 
6
 
 The nomo-
grams based on self-reported activity level (from
the second and third equations) are shown in Fig-
ure 2. The active women had a greater predicted ex-
ercise capacity for any given age than their more
sedentary counterparts.
Using the first regression equation to predict
normal exercise capacity for age and the equation
for the percentage of predicted exercise capacity
achieved for age, we determined the percentage of
predicted exercise capacity achieved for each par-
ticipant in both populations. The results ranged
from 20 percent to 150 percent of the predicted val-
ue for age.
 
exercise capacity and prognosis
 
In the asymptomatic cohort, there were 180 deaths
overall (3 percent) and 58 deaths from cardiac caus-
es (1 percent) during a mean follow-up of 8.4 years
(Table 1). Women in this cohort were assumed to
be alive if they were not identified as having died by
 
Figure 1. Nomogram of the Percentage of Predicted Exercise Capacity for Age in Asymptomatic Men and Women.
 
A line drawn from the patient’s age on the lefthand scale to the MET value on the righthand scale will cross the percent-
age line at the point corresponding to the patient’s percentage of predicted exercise capacity for age. The nomogram for 
men was modified from Morris et al.
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a search of the National Death Index. In the symp-
tomatic cohort, there were 537 deaths overall (12
percent) and 45 deaths from cardiac causes (1 per-
cent) during a mean follow-up of 5.3 years (Table
1); 3 percent of this cohort was lost to follow-up.
In the asymptomatic cohort, the women whose
exercise capacity was less than 85 percent of the
age-predicted value had a hazard ratio for death
from any cause of 2.03 (P<0.001) and a hazard ra-
tio for death from cardiac causes of 2.44 (P<0.001),
as compared with the women whose exercise ca-
pacity was at least 85 percent of the age-predicted
value (Table 2). In the asymptomatic cohort, as
compared with women whose exercise capacity ex-
ceeded the age-predicted value by more than 3 MET,
women whose exercise capacity was less than that
predicted for age (for whom the observed exercise
capacity minus the predicted exercise capacity was
less than 0 MET) had a hazard ratio for death from
any cause of 2.63 (P = 0.005) and for death from
cardiac causes of 4.27 (P = 0.045) (Table 2). The
amount of deviation from one’s age-predicted ex-
ercise capacity was correlated with the risk of
both death from any cause and death from cardiac
causes.
In the symptomatic population, as compared
with the women whose exercise capacity was at
least 85 percent of the age-predicted value, women
whose exercise capacity was less than 85 percent of
the age-predicted value had a hazard ratio for death
from any cause of 2.37 (P<0.001) and for death
from cardiac causes of 2.02 (P<0.001) (Table 2).
As compared with women whose exercise capac-
ity exceeded the age-predicted value by more than
3 MET, women whose exercise capacity was less
than that predicted for age (i.e., a deviation of less
than 0 MET) had a hazard ratio for death from any
cause of 3.28 (P<0.001) and for death from cardiac
causes of 3.80 (P<0.001) (Table 2). The relation-
ship between exercise capacity and the risk of death
from cardiac causes was remarkably similar for all
age groups in the symptomatic cohort, with two
 
Figure 2. Nomogram of the Percentage of Predicted Exercise Capacity for Age in Sedentary and Active Women 
in the Asymptomatic Cohort.
 
A line drawn from the patient’s age on the lefthand scale to the MET value on the righthand scale will cross the percent-
age line at the point corresponding to the patient’s percentage of predicted exercise capacity for age.
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exceptions. Young women (less than 55 years of
age) with a poor exercise capacity (for whom the ob-
served exercise capacity minus the predicted exer-
cise capacity was less than ¡2 MET) had an espe-
cially high mortality rate, as did the oldest women
(older than 70 years) for whom the observed exer-
cise capacity minus the predicted exercise capacity
was less than 1 MET (Fig. 3).
 
use of the nomogram
 
Use of the nomogram for the percentage of pre-
dicted exercise capacity for age (Fig. 1) requires only
the woman’s age and exercise capacity achieved (in
MET) on the exercise stress test. Drawing a straight
line between the age and exercise capacity will al-
low the determination of the percentage of pre-
dicted exercise capacity for age; a value of 100 per-
cent is the mean for any given age. Any result greater
than 100 percent indicates better-than-average per-
formance. Any result lower than 100 percent indi-
cates some degree of functional impairment for
age. For example, a 60-year-old woman whose ex-
ercise capacity was 7 MET on a Bruce-protocol ex-
ercise test would have achieved 100 percent of the
predicted exercise capacity for her age. In contrast,
a 35-year-old woman whose exercise capacity was
also 7 MET would have achieved 69 percent of her
age-predicted exercise capacity.
The first goal of this study was to define the mean
age-predicted exercise capacity for women, as de-
picted by the nomogram in Figure 1. Although such
a nomogram has been established for men and is
routinely used in clinical practice, no such nomo-
gram has been established for women, nor have
the previous findings in men been validated in the
female population.
A number of regression equations for predict-
ing exercise capacity in a variety of male popula-
tions have been described.
 
6,7,9-11
 
 Three of these
studies examined the relationship of exercise ca-
pacity to age in healthy men.
 
6,7,9
 
 For the asymp-
tomatic women in our study, the regression equa-
tion for predicting exercise capacity for age was
similar to the regression equations established for
healthy men.
 
6,7,9
 
 In particular, it was very similar
to the equation derived from the 244 healthy men
in the study by Morris et al.
 
6
 
: predicted MET=14.7¡
(0.11¬age), with an age-adjusted SD of 2.5 (r=
¡0.53, P<0.001). Both equations for asymptom-
atic men and women share the same constant in
the regression equation, and the coefficient differs
by only 0.02. Although this number appears small
at first glance, the coefficient is multiplied by age.
This means that the difference in the predicted ex-
ercise capacity for age between men and women
will increase as age increases. The nomograms for
men and women, when shown side by side, clear-
ly demonstrate the difference between the sexes
(Fig. 1).
Within our cohort of asymptomatic women, the
regression equation differed on the basis of self-
reported physical-activity status. Women were clas-
sified as either sedentary or active, on the basis of
one question regarding their participation in a reg-
ular activity program. Although the validity of this
discussion
 
* The reference group is women whose exercise capacity was at least 85 percent of that predicted for age.
 
† This group served as the reference group.
 
Table 2. Hazard Ratios for Death from Any Cause and from Cardiac Causes among Women, According to the Deviation 
from the Expected Exercise Capacity for Age.
Exercise Capacity Death from Any Cause Death from Cardiac Causes
 
Asymptomatic
Women
Symptomatic
Women
Asymptomatic
Women
Symptomatic
Women
 
hazard ratio (95 percent confidence interval)
 
Exercise capacity <85% of predicted value 
for age*
2.03 (1.51–2.71) 2.37 (1.90–2.97) 2.44 (1.46–4.09) 2.02 (1.43–2.85)
Observed exercise capacity minus 
predicted exercise capacity
>3 MET† 1.0 1.0 1.0 1.0
0–3 MET 1.70 (0.84–3.44) 1.89 (1.44–2.48) 2.02 (0.46–8.82) 2.21 (1.31–3.27)
<0 MET 2.63 (1.33–5.19) 3.28 (2.47–4.35) 4.27 (1.03–17.6) 3.80 (2.26–6.38)
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question has not been established, we have shown
a difference in achieved exercise capacity for any
age group on the basis of activity status; the more
physically active women had a greater exercise ca-
pacity at all ages.
The nomogram developed in the cohort of
asymptomatic women was also used to determine
the percentage of predicted exercise capacity in a
referral cohort of racially diverse women from six
institutions. Deviation from the established normal
values was a significant predictor of the risk of death
from any cause and from cardiac causes in both the
symptomatic and asymptomatic groups. The fur-
ther the deviation below the predicted normative
value, the greater the risk of death.
The use of the women’s nomogram results in a
more accurate assessment of prognosis among the
women than does the use of the men’s nomogram
in this group. The sensitivity and specificity of our
survival model for predicting the risk of death from
any cause among the asymptomatic women are 70
percent and 47 percent, respectively, when the wom-
en’s nomogram is used. In contrast, the sensitivi-
ty and specificity are 55 percent and 64 percent, re-
spectively, when the men’s nomogram is used. Use
of the men’s nomogram in our cohort would have
resulted in 800 more false positive results as com-
pared with the 30 fewer false negative results.
The chief limitation of our study is that the no-
mogram was created from data on a volunteer co-
hort of asymptomatic, mostly white women. The
referral population differed from the asymptomat-
ic cohort. Traditional cardiac risk factors were ex-
pected to be more prevalent in the symptomatic
population than in the asymptomatic population,
and indeed, these women were older and were more
likely to have hypertension and diabetes. The symp-
tomatic women were also more racially diverse,
with a stronger representation of black women.
Prior studies have suggested that clinicians should
use a nomogram for the particular population from
which it was created. However, the nomogram we
have developed was predictive of the risk of death
in the symptomatic group, with hazard ratios sim-
ilar to those in the asymptomatic group from which
it was derived. Whether another nomogram derived
 
Figure 3. Rate of Death from Cardiac Causes as a Function of the Deviation from the Expected Exercise Capacity for Age 
among Symptomatic Women.
 
The rate of death from cardiac causes was stratified according to the difference between the observed and predicted 
exercise capacity (in MET) in the various age groups.
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from a symptomatic cohort or from a population
with more black women would be a better predic-
tor of the risk of death in our referral cohort is open
to question. Such an approach could, however, im-
ply the need for a different nomogram for every
clinical population tested, an approach that is not
likely to be practical and that might in any case re-
sult in findings not very different from ours.
We estimated exercise capacity on the basis of
the speed and degree of incline of the treadmill. In
contrast, in the study by Morris et al., ventilatory
gas exchange was measured directly in asymptom-
atic men during the stress test.
 
6
 
 This distinction is
important, since determination of MET levels from
a stress test has been demonstrated to overestimate
the exercise capacity.
 
17-19
 
 If oxygen consumption
had been measured directly in our study popula-
tion, the nomograms for men and women would
presumably have differed even more.
Despite extensive research on the role of exer-
cise stress testing and exercise capacity, there
has been a paucity of data on women, particularly
asymptomatic women. Thus, what is normal or ex-
pected for healthy women has not been well estab-
lished. We have developed a nomogram for women
that can be used to predict a woman’s expected ex-
ercise capacity at any given age and have demon-
strated that the resulting measure is a predictor of
the risk of death in both asymptomatic and symp-
tomatic cohorts.
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